Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2021
September 13, 2021 at 07:40 pm IST
Share
Advanced Biomedical Technologies, Inc. announced earnings results for the third quarter ended July 31, 2021. For the third quarter, the company announced sales was USD 180 compared to USD 961 a year ago. Operating loss was USD 111,772 compared to USD 116,441 a year ago. Net loss was USD 198,713 compared to USD 205,225 a year ago. For the nine months, sales was USD 47,508 compared to USD 61,251 a year ago. Operating loss was USD 313,564 compared to USD 336,420 a year ago. Net loss was USD 559,846 compared to USD 478,666 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
Advanced Biomedical Technologies, Inc. is engaged in the business of designing, developing, manufacturing, and marketing of biomaterial internal fixation devices. The Companyâs primary products include Polymer Osteosynthesis Devices made of a proprietary material compositing of polyamide 6 (PA6), hydroxyapatite (HA) and poly (methyl methacrylate-co-N-vinylpyrrolidone) (P(MMA-co-NVP)). These advanced materials are used in surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials and its PA Mini-Screws are under animal test.